Omnicell aims to solve this problem. Its products, which consist of automated dispensing systems, medication cabinets and pharmacy robotics, ensure the right medication gets to the right person in ...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.

What a brutal six months it’s been for Omnicell. The stock has dropped 24.6% and now trades at $32.45, rattling many shareholders. This was partly driven by its softer quarterly results and may ...

But really big losses can really drag down an overall portfolio. So spare a thought for the long term shareholders of Omnicell, Inc. (NASDAQ:OMCL); the share price is down a whopping 75% in the ...

Omnicell’s OMCL strength in its SaaS and Expert Services offerings should help sustain growth in the upcoming quarters. Efforts to expand into overseas markets instill optimism. However, adverse ...

Omnicell OMCL underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...

But really big losses can really drag down an overall portfolio. So spare a thought for the long term shareholders of Omnicell, Inc. (NASDAQ:OMCL); the share price is down a whopping 75% in the last ...